Latest Articles
Kyobo Life Insurance has also released women-specific products as targeting women has emerged as an - 매일경제
Kyobo Life Insurance has also released women-specific products as targeting women has emerged as an 매일경제
Published: Oct. 10, 2025, 1:02 a.m.
Support Tere: Journey started with endometriosis but now battling Stage 4 metastatic cancer targeting her liver and lymph nodes - Givealittle
Support Tere: Journey started with endometriosis but now battling Stage 4 metastatic cancer targeting her liver and lymph nodes Givealittle
Published: Aug. 1, 2025, 10:56 p.m.
Neuroinflammation is responsible for pain in endometriosis -Targeting the JAK-STAT Pathway and Mast Cell Activation - Frontiers
Neuroinflammation is responsible for pain in endometriosis -Targeting the JAK-STAT Pathway and Mast Cell Activation Frontiers
Published: July 31, 2025, 8:44 p.m.
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight - The Malaysian Reserve
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight The Malaysian Reserve
Published: July 24, 2025, 10:55 p.m.
Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review - Frontiers
Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review Frontiers
Published: June 30, 2025, 12:38 p.m.
PBS sues Trump administration over executive order targeting public broadcasting - 6abc Philadelphia
PBS sues Trump administration over executive order targeting public broadcasting 6abc Philadelphia
Published: May 30, 2025, 10:55 p.m.
Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer - OncLive
Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer OncLive
Published: May 21, 2025, 2:09 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature
Published: April 1, 2025, 1:15 p.m.
Selective targeting of genes regulated by zinc finger proteins in endometriosis and endometrioid adenocarcinoma by zinc niflumato complex with neocuproine - Nature.com
Selective targeting of genes regulated by zinc finger proteins in endometriosis and endometrioid adenocarcinoma by zinc niflumato complex with neocuproine Nature.com
Published: March 24, 2025, 4:17 p.m.
AstraZeneca spotlights first-in-human data for B7-H4-targeting ADC in endometrial cancer - Endpoints News
AstraZeneca spotlights first-in-human data for B7-H4-targeting ADC in endometrial cancer Endpoints News
Published: March 17, 2025, 11:20 a.m.
Link copied to clipboard!